Status:
RECRUITING
Stimulating the Cochlear Apex Without Longer Electrodes
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions:
Deafness With a Cochlear Implant
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
The most common cochlear implant intervention provides an electrode array that stimulates less than half of the length of the cochlea, leaving the regions which represent lower frequencies in the norm...
Eligibility Criteria
Inclusion
- Participants in this study must have already been evaluated at the NYU cochlear implant center as being eligible for a cochlear implant.
- They must have decided to receive a cochlear implant manufactured by Cochlear Limited and have been diagnosed with a moderate to profound sensorineural hearing loss in the ear to be implanted.
- Individuals who have already been implanted with a cochlear implant manufactured by Cochlear Limited with or without this new approach may also participate in this study.
Exclusion
- They are under the age of 18
- They have not been diagnosed with a moderate to profound sensorineural hearing loss in the ear to be implanted
- Have \>15 years of profound deafness
- Have not chosen to receive a cochlear implant manufactured by Cochlear Limited
- Are pregnant or plan to conceive within 6 months of consenting
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06901674
Start Date
August 1 2022
End Date
January 1 2026
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016